- Home
- COYA vs OPRX Comparison
COYA vs OPRX Comparison
Compare COYA & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COYA | OPRX |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.0M | 117.1M |
| IPO Year | 2022 | 2008 |
Fundamental Metrics
Financial Performance| Metric | COYA | OPRX |
|---|---|---|
| Price | $4.61 | $7.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $15.80 | ★ $16.67 |
| AVG Volume (30 Days) | 89.9K | ★ 225.3K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ N/A |
| Revenue | $7,945,753.00 | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | $763.10 | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 123.57 | 18.78 |
| 52 Week Low | $3.71 | $4.54 |
| 52 Week High | $7.75 | $22.25 |
Technical Indicators
Market Signals| Indicator | COYA | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.84 | 52.05 |
| Support Level | $4.45 | $5.85 |
| Resistance Level | $5.19 | $8.26 |
| Average True Range (ATR) | 0.24 | 0.45 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 36.11 | 12.41 |
Price Performance
Historical ComparisonAbout COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.